StockData
GENELUX Corp logo

GENELUX Corp (GNLX) stock

GNLXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$2.28+0.04 (+1.79%)

Close on Nov 19, 2026Market cap $103.16MP/E –Yield –

Genelux shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Genelux's shares outstanding was 45M at Jun 30, 2026. For fiscal 2025 it was 37M, up 18.2% from the year before.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202537M+18.2%
FY2024Dec 31, 202431M+28.7%
FY2023Dec 31, 202324M+168.0%
FY2022Dec 31, 20229M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202645M+18.5%
Q1 FY2026Mar 31, 202644M+26.4%
Q4 FY2025Dec 31, 202538M+10.2%
Q3 FY2025Sep 30, 202538M+9.7%
Q2 FY2025Jun 30, 202538M+27.8%
Q1 FY2025Mar 31, 202535M+30.1%
Q4 FY2024Dec 31, 202435M+29.1%
Q3 FY2024Sep 30, 202435M+31.8%
Q2 FY2024Jun 30, 202430M+18.4%
Q1 FY2024Mar 31, 202427M+37.2%
Q4 FY2023Dec 31, 202327M+193.6%
Q3 FY2023Sep 30, 202326M+160.2%
Q2 FY2023Jun 30, 202325M+175.1%
Q1 FY2023Mar 31, 202320M+114.9%
Q4 FY2022Dec 31, 20229M–
Q3 FY2022Sep 30, 202210M–
Q2 FY2022Jun 30, 20229M–
Q1 FY2022Mar 31, 20229M–

More Genelux figures

See a number that looks wrong?